Research ArticleArticle
Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent Mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology April 2009, 75 (4) 782-792; DOI: https://doi.org/10.1124/mol.108.052928
Takero Nakajima
Naoki Tanaka
Hiroki Kanbe
Atsushi Hara
Yuji Kamijo
Xiaowei Zhang
Frank J. Gonzalez
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent Mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology April 1, 2009, 75 (4) 782-792; DOI: https://doi.org/10.1124/mol.108.052928
Research ArticleArticle
Bezafibrate at Clinically Relevant Doses Decreases Serum/Liver Triglycerides via Down-Regulation of Sterol Regulatory Element-Binding Protein-1c in Mice: A Novel Peroxisome Proliferator-Activated Receptor α-Independent Mechanism
Takero Nakajima, Naoki Tanaka, Hiroki Kanbe, Atsushi Hara, Yuji Kamijo, Xiaowei Zhang, Frank J. Gonzalez and Toshifumi Aoyama
Molecular Pharmacology April 1, 2009, 75 (4) 782-792; DOI: https://doi.org/10.1124/mol.108.052928
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement